Rune Skovgaard Rasmussen

Rune Skovgaard Rasmussen serves as a Part-time Lecturer at the Biotech Research and Innovation Centre (BRIC), University of Copenhagen. His academic work is deeply embedded in neuroscience and stroke research, with particular emphasis on neuroimmune interactions following cerebrovascular events.

His research spans Neuroscience, Neurology, Stroke Pathology, Immunology, and Cardiovascular Diagnostics. Key investigations include temporal immune cell dynamics post-stroke, biomarker validation (notably N-acetyl aspartate), infection-stroke interactions, and therapeutic interventions like statin pretreatment and testosterone-resistance training combinations. His methodology integrates clinical studies with experimental models to elucidate mechanisms of neuroinflammation and brain damage.

Analysis of his 2016-2024 publications reveals three dominant trajectories: (1) Immune cell profiling timelines showing T-cell/macrophage peaks weeks after stroke, (2) Biomarker development for predicting long-term outcomes, and (3) Translational studies evaluating pharmacological (statins) and physiological (testosterone/training) interventions. His work consistently bridges basic neuroimmunology with clinical applications.

Rasmussen operates within BRIC's collaborative ecosystem at the University of Copenhagen, engaging with multiple research groups across neurology, cardiology, and infectious disease specialties as evidenced by his extensive co-authorship network. His ORCID (0000-0002-5630-122X) documents 24 research outputs with significant clinical impact.